Syncromune®
The Associate Director of CMC Analytical Development will lead the analytical strategy for drug substance and drug product development across all clinical phases and commercialization, overseeing method development, validation, transfer, and lifecycle management. The role provides technical leadership, guides cross‑functional collaboration, and ensures compliance with GMP, ICH, and FDA regulations while supporting regulatory submissions.
Headquarters
Fort Lauderdale, Florida, United States
Syncromune® is developing SYNC-T®, a platform immunotherapy designed to synchronize the location of 3 key components needed to educate the immune system to recognize and attack cancer. Now enrolling LEGION-100 trial for metastatic castration-resistant prostate cancer. www.legion100trial.com
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Syncromune®.
13% below the average for this role
Analytical Lead
Neurocrine Biosciences
Senior Scientist, Analytical Chemistry
Merck & Co., Inc.
Lead and mentor the Oligonucleotide & Small Molecule CMC Analytical Development team
Denali Therapeutics
Advisor, Analytical Chemistry
Eli Lilly and Company
Analytical Development, Senior Manager
Intuitive
Laboratory Analytical Scientist
AstraZeneca